Several Options for Frontline Treatment of MCL
In this MEDtalk from EHA 2025, Professor Mats Jerkeman, MD, PhD, from Lund University and Skåne University Hospital, highlights several possible frontline treatment strategies in mantle cell lymphoma that incorporate BTK inhibitors. He provides his perspective on frontline treatment strategies for younger MCL patients as well as older and high-risk patients.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
